TYRA
Tyra Biosciences·NASDAQ
--
--(--)
--
--(--)
TYRA Filings
Filing Date
Form Description
Form Type
2026-04-02
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-04-02 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-04-02
Form 8-K - Current report
Key Events
2026-04-02 · Key Events
Form 8-K - Current report
2026-03-27
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-27 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-26
Form 144 - Report of proposed sale of securities
Ownership
2026-03-26 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-25
Form 144 - Report of proposed sale of securities
Ownership
2026-03-25 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-12
Form 144 - Report of proposed sale of securities
Ownership
2026-03-12 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-06
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-06 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-04
Form 8-K - Current report
Key Events
2026-03-04 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
